Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Decades of inaction to curb the overuse of life-saving antibiotics by physicians, dentists, patients, and farmers has created hard-to-treat "superbugs" that are spreading and growing stronger, with dire consequences, according to Consumer Reports.
read more
Huntingdon Life Sciences and Harlan Laboratories have announced that the combined companies will be called Envigo.
read more
The current global discovery outsourcing market of cancer immunotherapy is about $2.8 B. In the past five years (2010 - 2014), its CAGR was about 37%. Based on analysis, Research and Markets forecast that the global cancer immunotherapy-focused drug ...
read more
Forty-five percent of Americans who use opioid prescription painkillers do not realize they are taking an opioid, or that the drug is just as addictive as heroin, according to a National Safety Council survey
read more
SGS Life Science Services has announced the completed construction of its Shanghai, China, cGMP chemistry and biotechnology testing laboratories.
read more
Unique Pharmaceuticals, a 503B current Good Manufacturing Practices (CGMP) Outsourcing Facility, has announced its licensure approval in Florida.
read more
Medical marijuana has not been proven to work for many illnesses that state laws have approved it for, according to the first comprehensive analysis of research on its potential benefits.
read more
The House on Tuesday approved a bipartisan bill that would update regulation of harmful chemicals for the first time in nearly 40 years.
read more
Metrics Contract Services (Metrics) has purchased state-of-the-art analytical laboratory equipment to better serve pharmaceutical clients whose drug products now must undergo heightened elemental impurities testing, thanks to new international ...
read more
Study Connect™, a new mobile app from Merge eClinical, allows eClinicalOS (eCOS) users to perform a wide array of clinical trial management functions from their iOS-based mobile devices.
read more
Intas Pharmaceuticals has launched RAZUMAB™, its biosimilar to Lucentis® (Ranibizumab). Intas is the first company globally to develop and launch a biosimilar version of Ranibizumab.
read more
Alexza Pharmaceuticals has updated and amended its ADASUVE® (Staccato® loxapine) commercial partnerships with Grupo Ferrer Internacional, S.A. and Teva Pharmaceutical Industries Ltd.
read more
Sandoz, a Novartis company, has announced the US launch of GlatopaTM, the first generic version of Teva's Copaxone® (glatiramer acetate injection) 20 mg/ml one-time-daily multiple sclerosis therapy.
read more
A high-ranking Senate Democrat is probing retailers and online companies about sales of dubious dietary supplements, especially those promising seniors protection from memory loss, dementia and other age-related problems.
read more
A survey of biopharmaceutical dealmakers by Campbell Alliance, the consulting firm of inVentiv Health, suggests that 2015 will set a new record for mergers and acquisitions and licensing of biopharmaceutical assets.
read more